13 oct 2020
CPhI Worldwide 2020
Syngene International Ltd.

Syngene International Ltd.

Exhibitor at CPhI Worldwide 2020 stand 4J43, CRO & Clinical Trials Zone

About us

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an innovation focused global discovery, development and manufacturing organisation providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele include world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 4000-strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speed time to market and lower the cost of innovation. For more details, visit www.syngeneintl.com.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Clinical Research (Field) More

Products featured at CPhI Worldwide 2020

Syngene International Ltd.

Event information

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 4J43